File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.jval.2024.03.2119
- Find via

Supplementary
-
Citations:
- Appears in Collections:
Article: PCR241 Behavioral Economics-Based Financial and Social Incentives for Weight Loss in Newly Diagnosed Type 2 Diabetes: A Randomized Control Trial
| Title | PCR241 Behavioral Economics-Based Financial and Social Incentives for Weight Loss in Newly Diagnosed Type 2 Diabetes: A Randomized Control Trial |
|---|---|
| Authors | |
| Issue Date | 1-Jun-2024 |
| Publisher | Elsevier |
| Citation | Value in Health, 2024, v. 27 How to Cite? |
| Abstract | Objectives Weight loss is a crucial in controlling type 2 diabetes mellitus. We assessed the effectiveness of financial and social incentives using behavioral economics to reduce body weight in patients with newly diagnosed type 2 diabetes. Methods We conducted a pragmatic randomized clinical trial with a 6-month intervention period from June 2021 to December 2023. Adults with newly diagnosed type 2 diabetes recruited at public primary care clinics. Participants were randomly assigned to three groups to incentive increased physical activity: financial incentive, financial and social incentive, and control. Participants in the incentive groups received personalized weekly step targets along with loss-framed financial incentives starting at $128 USD (HKD 1000). Participants lost $5 USD each week if their step target was not met. For the social incentive, participant weekly step performance was shared with their nominated supporters to provide peer encouragement. Intent-to-treat analysis using weighted generalized estimating equations (WGEE) was performed to assess changes in body weight. ClinicalTrials.gov identifier: NCT04917926 Results Among 104 adults newly diagnosed with type 2 diabetes, the mean age was 55.0 (53.9% female). Median baseline weight for the control group was 66.2kg (IQR: 16.85kg; BMI: 25.8), the financial incentive group was 72.0 kg (IQR: 25.0kg; BMI: 26.3), and the combined financial and social incentive group was 66.1kg (IQR: 17.9kg; BMI: 25.7). Compared to the control group, significant weight loss occurred at 6-months in the social incentive group (-2.41 kg, p=0.015). Participants from the financial incentive group showed a non-significant decrease in weight (-0.46 kg).Participants in both incentive groups had non-significant increases in daily step counts (financial incentive: 907, financial and social incentive: 1752). Mean payout for financial incentives was USD 100.67 and financial and social incentives was USD 113.38. Conclusions Financial incentives with peer support can achieve weight loss in patients newly diagnosed with type 2 diabetes. |
| Persistent Identifier | http://hdl.handle.net/10722/356044 |
| ISSN | 2023 Impact Factor: 4.9 2023 SCImago Journal Rankings: 1.507 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lai, CW | - |
| dc.contributor.author | Kwok, HH | - |
| dc.contributor.author | Ye, J | - |
| dc.contributor.author | Ng, CS | - |
| dc.contributor.author | Quan, J | - |
| dc.date.accessioned | 2025-05-22T00:35:19Z | - |
| dc.date.available | 2025-05-22T00:35:19Z | - |
| dc.date.issued | 2024-06-01 | - |
| dc.identifier.citation | Value in Health, 2024, v. 27 | - |
| dc.identifier.issn | 1098-3015 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/356044 | - |
| dc.description.abstract | <p>Objectives</p><p>Weight loss is a crucial in controlling type 2 diabetes mellitus. We assessed the effectiveness of financial and social incentives using behavioral economics to reduce body weight in patients with newly diagnosed type 2 diabetes.</p><p>Methods</p><p>We conducted a pragmatic randomized clinical trial with a 6-month intervention period from June 2021 to December 2023. Adults with newly diagnosed type 2 diabetes recruited at public primary care clinics. Participants were randomly assigned to three groups to incentive increased physical activity: financial incentive, financial and social incentive, and control. Participants in the incentive groups received personalized weekly step targets along with loss-framed financial incentives starting at $128 USD (HKD 1000). Participants lost $5 USD each week if their step target was not met. For the social incentive, participant weekly step performance was shared with their nominated supporters to provide peer encouragement. Intent-to-treat analysis using weighted generalized estimating equations (WGEE) was performed to assess changes in body weight. ClinicalTrials.gov identifier: NCT04917926</p><p>Results</p><p>Among 104 adults newly diagnosed with type 2 diabetes, the mean age was 55.0 (53.9% female). Median baseline weight for the control group was 66.2kg (IQR: 16.85kg; BMI: 25.8), the financial incentive group was 72.0 kg (IQR: 25.0kg; BMI: 26.3), and the combined financial and social incentive group was 66.1kg (IQR: 17.9kg; BMI: 25.7). Compared to the control group, significant weight loss occurred at 6-months in the social incentive group (-2.41 kg, p=0.015). Participants from the financial incentive group showed a non-significant decrease in weight (-0.46 kg).Participants in both incentive groups had non-significant increases in daily step counts (financial incentive: 907, financial and social incentive: 1752). Mean payout for financial incentives was USD 100.67 and financial and social incentives was USD 113.38.</p><p>Conclusions</p><p>Financial incentives with peer support can achieve weight loss in patients newly diagnosed with type 2 diabetes.</p> | - |
| dc.language | eng | - |
| dc.publisher | Elsevier | - |
| dc.relation.ispartof | Value in Health | - |
| dc.title | PCR241 Behavioral Economics-Based Financial and Social Incentives for Weight Loss in Newly Diagnosed Type 2 Diabetes: A Randomized Control Trial | - |
| dc.type | Article | - |
| dc.identifier.doi | 10.1016/j.jval.2024.03.2119 | - |
| dc.identifier.volume | 27 | - |
| dc.identifier.eissn | 1524-4733 | - |
| dc.identifier.issnl | 1098-3015 | - |
